Breaking News Instant updates and real-time market news.

GFN

General Finance Corp

$4.95

0.2 (4.21%)

, MWA

Mueller Water

$12.22

0.065 (0.53%)

13:25
09/19/17
09/19
13:25
09/19/17
13:25

DA Davidson holds a conference

16th Annual Engineering & Construction Conference is being held in Chicago on September 19-20 with webcasted company presentations to begin on September 19 at 2pm; not all company presentations may be webcasted. Webcast Link

GFN

General Finance Corp

$4.95

0.2 (4.21%)

MWA

Mueller Water

$12.22

0.065 (0.53%)

SSN

Samson Oil & Gas

$0.33

(0.00%)

EME

EMCOR

$68.78

0.235 (0.34%)

LPX

Louisiana-Pacific

$27.18

-0.03 (-0.11%)

VMI

Valmont

$152.80

0.35 (0.23%)

MTZ

MasTec

$45.53

0.925 (2.07%)

MTRX

Matrix Service

$14.60

(0.00%)

APOG

Apogee Enterprises

$44.98

0.18 (0.40%)

WG

Willbros Group

$2.93

0.01 (0.34%)

STN

Stantec

$28.30

0.35 (1.25%)

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

GFN General Finance Corp
$4.95

0.2 (4.21%)

MWA Mueller Water
$12.22

0.065 (0.53%)

09/05/17
09/05/17
UPGRADE
Target $14

Outperform
Follow-up: Mueller Water upgraded to Outperform at Boenning & Scattergood
As previously reported, Boenning & Scattergood upgraded Mueller Water to Outperform from Neutral with a $14 price target. Analyst Ryan Connors expects sustained demand for basic water infrastructure products due to the positive outlook for home building, and in particular land development as builders seek to bring new housing supply to market. Connors said Mueller has a significant strategic optionality and a recent track record of bold portfolio management moves, with over $2/share in cash and an attractive systems business that has significant franchise value while shares trade at a 21% discount to water infrastructure peers.
09/05/17
BOSC
09/05/17
UPGRADE
BOSC
Outperform
Mueller Water upgraded to Outperform from Neutral at Boenning & Scattergood
04/11/17
NOMU
04/11/17
INITIATION
Target $74
NOMU
Buy
Owens Corning initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Wood started Owens Corning (OC) with a Buy rating and $74 price target. The stock is one of the analyst's top ideas in the Building Products sector along with Mueller Water (MWA), Mohawk Industries (MHK) and Armstrong World (AWI).
04/11/17
NOMU
04/11/17
INITIATION
Target $15
NOMU
Buy
Mueller Water initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Wood started Mueller Water Products with a Buy rating and $15 price target.
SSN Samson Oil & Gas
$0.33

(0.00%)

EME EMCOR
$68.78

0.235 (0.34%)

01/13/17
MACQ
01/13/17
INITIATION
Target $73
MACQ
Neutral
EMCOR initiated with a Neutral at Macquarie
Macquarie analyst John D'Angelo initiated EMCOR with a Neutral and a $73 price target citing full valuation.
02/24/17
STFL
02/24/17
UPGRADE
STFL
Buy
EMCOR upgraded based on valuation at Stifel
As noted earlier, Stifel upgraded EMCOR to Buy from Hold. Analyst Noelle Dilts upgraded the stock based on valuation. Target to $68 from $70.
02/24/17
STFL
02/24/17
UPGRADE
STFL
Buy
EMCOR upgraded to Buy from Hold at Stifel
01/25/17
SIDC
01/25/17
NO CHANGE
Target $90
SIDC
Buy
EMCOR infrastructure spending will extend non-residential cycle, says Sidoti
Tate Sullivan believes government spending on infrastructure will extend the current cycle of growth in nonresidential construction for the next three years. When EMCORE reports Q4 results in late February, the anlyst expects initial 2017 earnings guidance of $3.25-$3.55, which at the low end implies growth, unlike 2016 guidance. Sullivan expects shares to react positively in 2017 as confidence rises in the company's ability to post earnings growth for at least the next three years. The analyst rates EMCOR a Buy with a $90 price target.
LPX Louisiana-Pacific
$27.18

-0.03 (-0.11%)

04/12/17
BUCK
04/12/17
DOWNGRADE
Target $27
BUCK
Neutral
Louisiana-Pacific downgraded to Neutral on valuation at Buckingham
Buckingham downgraded Louisiana-Pacific to Neutral from Buy and raised its price target to $27 from $26 citing recent share strength that has made risk/reward more balanced.
04/12/17
04/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Sell from Hold at Rafferty Capital with analyst Richard Bove saying he does not expect bank stocks in general to do well for months and he thinks on Wells specifically that its Directors report indicates that the company is in the midst of a multi-year re-structuring process. Bove lowered his 12-month price target range for Wells Fargo shares to $46-$60 from $52-$68. 2. Tractor Supply (TSCO) was downgraded to Equal Weight from Overweight at Stephens and to Neutral from Overweight at JPMorgan. 3. Avinger (AVGR) downgraded to Perform from Outperform at Oppenheimer with analyst Steven Lichtman downgraded Avinger (AVGR) to Perform from Outperform after its Q1 sales came in below estimates on lower than expected Pantheris utilization and following the company's announcement that it plans to reduce its workforce by 33%, while pursuing strategic alternatives, including a capital raise from strategic investors, OUS partnerships, or a merger/sale. 4. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength that has made risk/reward more balanced. 5. LVMH (LVMUY) downgraded to Hold from Buy at Societe Generale with analyst Thierry Cota citing a lack of upside following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/17
DADA
05/08/17
DOWNGRADE
Target $27
DADA
Neutral
Louisiana-Pacific downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Steven Chercover downgraded Louisiana-Pacific to Neutral citing valuation following the company's Q1 results. The analyst believes "much of the good news on commodities" is already priced into the shares. He has a $27 price target for the stock.
05/08/17
05/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs analyst Mark Delaney downgraded Micron (MU) Technology to Neutral from Buy and lowered his price target for the shares to $30 from $32. With consensus estimates up 70% for the current fiscal year on better memory prices and margins, the major catalyst for shares has already played out, Delaney tells investors. 2. Bank of America Merrill Lynch analyst Steve Byrne downgraded LyondellBasell (LYB) two notches to Underperform from Buy and lowered its price target to $80 from $100, telling investors supply growth is set to impact margins. The analyst said polyethylene industry is over-earning and capacity has accelerated and will result in global polyethylene supply growth that is expected to exceed demand through 2018. 3. Goldman Sachs analyst Toshiya Hari removed Lam Research (LRCX) from the Conviction Buy List given recent outperformance. The analyst maintains a Buy rating and increased his price target to $160 from $153, citing strong industry fundamentals and market share gains, among other reasons. 4. Deutsche Bank analyst Jonathan Arnold downgraded Consolidated Edison (ED) to Sell saying the valuation is "stretched" at current share levels. The analyst sees 7% downside to his unchanged price target of $74. 5. DA Davidson analyst Steven Chercover downgraded Louisiana-Pacific (LPX) to Neutral citing valuation following the company's Q1 results, as he believes "much of the good news on commodities" is already priced into the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VMI Valmont
$152.80

0.35 (0.23%)

06/27/17
FBCO
06/27/17
NO CHANGE
FBCO
Underperform
Valmont CEO change should not surprise investors, says Credit Suisse
After Valmont announced that Stephen Kaniewski will be succeeding Mogens Bay as CEO, Credit Suisse analyst Julian Mitchell said the move should not come as a surprise to investors as Kaniewski's COO position was widely viewed as a stepping stone into the CEO role. Mitchell, who anticipates Kaniewski will reiterate the company's long term financial targets and expects the portfolio to remain largely intact, keeps an Underperform rating on Valmont shares.
04/20/17
DADA
04/20/17
NO CHANGE
DADA
Valmont performance improving, says DA Davidson
After Valmont reported stronger than expected Q1 results but reiterated its full-year guidance, DA Davidson analyst Brent Thielman says that the company's revenue is "beginning to rebound," while its margins have "stabilized." The analyst sees "encouraging signs" in its Utility Structures and Irrigation segments. He keeps a Buy rating on the shares.
08/11/17
BOSC
08/11/17
UPGRADE
BOSC
Outperform
Valmont upgraded to Outperform from Neutral at Boenning & Scattergood
09/06/17
GHSC
09/06/17
INITIATION
Target $160
GHSC
Buy
Valmont initiated with a Buy at Seaport Global
Seaport Global analyst Michael Shilisky initiated Valmont with a Buy and a $160 price target. The analyst said many of Valmont's end markets are at trough levels and have begun to show signs of improvement and believes the company's Engineered Support Structures unit is poised to continue with its modest recovery.
MTZ MasTec
$45.53

0.925 (2.07%)

08/17/17
STFL
08/17/17
NO CHANGE
STFL
MasTec has reached attractive entry point, says Stifel
Stifel analyst Noelle C. Dilts, noting that MasTec has declined 15% since August 3, believes that the stock has reached an attractive entry point. She thinks that investors are worried that the company's profit won;t increase next year, but she continues to believe that this will occur. After attending investor meetings with the company's head of IR, the analyst is confident that the company will have "a number of growth driver" next year and that it is currently " in the advanced stages of negotiating on a significant amount of large pipeline project work." Dilts thinks that the stock has reached an attractive entry point and keeps a Buy rating on the shares.
08/18/17
SBSH
08/18/17
UPGRADE
Target $49
SBSH
Buy
MasTec upgraded to Buy from Neutral at Citi
Citi analyst Andrew Kaplowitz upgraded MasTec (MTZ) to Buy saying the recent pullback in the shares provides a buying a good entry point. The company has above average earnings growth potential relative to reduced expectations, Kaplowitz tells investors in a research note. He keeps a $49 price target for the shares. Kaplowitz this morning also upgraded Quanta Services (PWR) to Buy.
08/18/17
08/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Rentals (URI) upgraded to Buy from Hold at Stifel with analyst Stanley Elliott saying that the company's acquisition of Neff (NEFF) increases his confidence in its outlook and leaves it better positioned to exploit favorable demand trends. 2. Tonix Pharmaceuticals (TNXP) upgraded to Buy from Neutral at Roth Capital with analyst Scott Henry believes Tonix's current valuation does not reflect the potential of the Tonmya program to treat PTSD and said the company has the cash runway to reach pivotal data readout in both first half 2018 and second half 2018. 3. Quanta Services (PWR) and MasTec (MTZ) were upgraded to Buy from Neutral at Citi. 4. Howard Bancorp (HBMD) upgraded to Overweight from Equal Weight at Stephens with analyst Austin Nicholas saying the in-market acquisition of 1st Mariner strategically deploys Howard's excess capital, creating the #1 community bank in Baltimore. 5. Myriad Genetics (MYGN) upgraded to Hold from Sell at Deutsche Bank with analyst Dan Leonard saying the risk/reward is now balanced following the company's weaker than expected FY18 outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/12/17
DBAB
09/12/17
UPGRADE
Target $50
DBAB
Buy
MasTec upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Chad Dillard upgraded MasTec (MTZ) to Buy saying the recent share weakness provides an attractive entry point. Concerns about peak pipeline EBITDA and slowing AT&T (T) spending are overblown, Dillard tells investors in a research note. He sees several catalysts that could drive better than expected earnings growth in 2018 and beyond. The analyst keeps a $50 price target for the shares.
MTRX Matrix Service
$14.60

(0.00%)

11/18/16
AVON
11/18/16
DOWNGRADE
AVON
Market Perform
Matrix Service downgraded to Market Perform from Outperform at Avondale
Avondale analyst Daniel Mannes downgraded Martrix Service to Market Perform with a $19 price target saying valuation is full pending recovery in OG&C and/or deployment of capital.
05/15/17
05/15/17
DOWNGRADE

Equal Weight
Matrix Service downgraded to Equal Weight from Overweight at Stephens
As previously reported, Stephens analyst Matt Duncan reinstated coverage of Matrix Service with an Equal Weight rating, saying its troubled project is likely to continue to weigh on the shares. Prior to suspending coverage of the stock, Duncan had an Overweight rating on the shares.
APOG Apogee Enterprises
$44.98

0.18 (0.40%)

08/24/17
DADA
08/24/17
NO CHANGE
DADA
Apogee Enterprises weakness overdone, says DA Davidson
DA Davidson analyst Brent Thielman says that the reduction in Apogee's fiscal 2018 guidance "raises concerns" about its "M&A and mid-size glass market penetration strategies." However, the analyst thinks that the weakness in the stock was overdone, and he remains upbeat on the company's fiscal 2019 outlook. The analyst cut his price target on the stock to $52 from $65 but keeps a Buy rating on the shares.
05/25/17
SIDC
05/25/17
INITIATION
SIDC
Buy
Apogee Enterprises re-initiated with a Buy at Sidoti
04/17/17
CHLM
04/17/17
NO CHANGE
Target $68
CHLM
Buy
Apogee Enterprises pullback creates buying opportunity, says Craig-Hallum
Craig-Hallum analyst Eric Stine notes that Apogee Enterprises reported "solid 4Q results," but points out that the pullback on misplaced concerns over non-re construction cycle due to 2018 revenue guidance creates a buying opportunity. The analyst reiterates a Buy rating and $68 price target.
01/19/17
01/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) and lululemon (LULU) were initiated with an Underperform at CLSA, while the firm initiated Under Armour (UA, UAA) with a Buy. 2. Comcast (CMCSA) was initiated with a Buy at HSBC, while Charter (CHTR) was initiated with a Hold. 3. Brookfield (BAM) initiated with a Buy at Citi. 4. Apogee Enterprises (APOG) initiated with a Buy at Craig-Hallum. 5. Infinera (INFN) initiated with a Neutral at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
WG Willbros Group
$2.93

0.01 (0.34%)

STN Stantec
$28.30

0.35 (1.25%)

05/12/17
DESJ
05/12/17
UPGRADE
DESJ
Buy
Stantec upgraded to Buy from Hold at Desjardins
Desjardins analyst Benoit Poirier upgraded Stantec to Buy from Hold citing attractive valuation, FX tailwinds, and improved growth prospects.
02/24/17
SCOT
02/24/17
UPGRADE
SCOT
Outperform
Stantec upgraded to Outperform from Sector Perform at Scotiabank

TODAY'S FREE FLY STORIES

03:15
11/15/18
11/15
03:15
11/15/18
03:15
General news
FX Action: USD-CAD has settled in the lower 1.3200s »

FX Action: USD-CAD has…

02:30
11/15/18
11/15
02:30
11/15/18
02:30
General news
FX Update: The Dollar has traded broadly softer »

FX Update: The Dollar has…

01:50
11/15/18
11/15
01:50
11/15/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

APTX

Aptinyx

$24.75

-0.76 (-2.98%)

21:40
11/14/18
11/14
21:40
11/14/18
21:40
Initiation
Aptinyx initiated at Cantor Fitzgerald »

Aptinyx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.75

-0.42 (-8.12%)

21:39
11/14/18
11/14
21:39
11/14/18
21:39
Initiation
Ovid Therapeutics initiated at Cantor Fitzgerald »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AXSM

Axsome Therapeutics

$2.82

-0.07 (-2.42%)

21:38
11/14/18
11/14
21:38
11/14/18
21:38
Initiation
Axsome Therapeutics initiated at Cantor Fitzgerald »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$17.53

0.24 (1.39%)

21:37
11/14/18
11/14
21:37
11/14/18
21:37
Initiation
Denali Therapeutics initiated at Cantor Fitzgerald »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$2.34

-0.07 (-2.90%)

21:35
11/14/18
11/14
21:35
11/14/18
21:35
Initiation
Otonomy initiated at Cantor Fitzgerald »

Otonomy initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AAPL

Apple

$186.81

-5.42 (-2.82%)

20:46
11/14/18
11/14
20:46
11/14/18
20:46
Hot Stocks
Apple supplier AMS AG discontinues FY18 targets »

Ams updates its fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WEI

Weidai

$0.00

(0.00%)

20:33
11/14/18
11/14
20:33
11/14/18
20:33
Syndicate
Weidai 4.5M share IPO priced at $10.00 »

The deal was priced at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CPB

Campbell Soup

$39.16

-0.1 (-0.25%)

20:31
11/14/18
11/14
20:31
11/14/18
20:31
Hot Stocks
Campbell Soup responds to ISS regarding board elections »

Campbell Soup issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CRM

Salesforce

$129.25

-2.93 (-2.22%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Periodicals
Breaking Periodicals news story on Salesforce »

Salesforce to accommodate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

WMT

Walmart

$101.58

-1.37 (-1.33%)

, JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

20:25
11/14/18
11/14
20:25
11/14/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WMT

Walmart

$101.58

-1.37 (-1.33%)

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

BERY

Berry Global

$45.91

-0.49 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

BHVN

Biohaven Pharmaceutical

$33.70

-3.18 (-8.62%)

19:53
11/14/18
11/14
19:53
11/14/18
19:53
Recommendations
Biohaven Pharmaceutical analyst commentary at Piper Jaffray »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

LOXO

Loxo Oncology

$143.69

-15.62 (-9.80%)

19:51
11/14/18
11/14
19:51
11/14/18
19:51
Initiation
Loxo Oncology initiated at Raymond James »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

OCUL

Ocular Therapeutix

$5.06

-0.25 (-4.71%)

19:50
11/14/18
11/14
19:50
11/14/18
19:50
Initiation
Ocular Therapeutix initiated at Raymond James »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Dec

VYGR

Voyager Therapeutics

$11.25

-0.54 (-4.58%)

19:49
11/14/18
11/14
19:49
11/14/18
19:49
Upgrade
Voyager Therapeutics rating change at Raymond James »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GLPG

Galapagos NV

$103.79

1.03 (1.00%)

19:48
11/14/18
11/14
19:48
11/14/18
19:48
Initiation
Galapagos NV initiated at Raymond James »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COPY

CopyTele

$0.00

(0.00%)

19:47
11/14/18
11/14
19:47
11/14/18
19:47
Upgrade
CopyTele rating change at BMO Capital »

CopyTele upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$21.43

-0.04 (-0.19%)

19:40
11/14/18
11/14
19:40
11/14/18
19:40
Syndicate
VICI Properties 30M share Secondary priced at $21.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

WHD

Cactus

$32.37

-0.7 (-2.12%)

19:37
11/14/18
11/14
19:37
11/14/18
19:37
Hot Stocks
Cactus names Stephen Tadlock new CFO »

Cactus announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVLT

Revolution Lighting

$1.42

(0.00%)

19:32
11/14/18
11/14
19:32
11/14/18
19:32
Hot Stocks
Revolution Lighting receives revised $1.50 per share proposal from RVL LLC »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$8.34

-0.265 (-3.08%)

19:20
11/14/18
11/14
19:20
11/14/18
19:20
Periodicals
General Electric withdraws from Nigeria rail concession, Reuters says »

GE has withdrawn from a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCSF

Bain Capital Specialty Finance

$0.00

(0.00%)

19:11
11/14/18
11/14
19:11
11/14/18
19:11
Syndicate
Bain Capital Specialty Finance 7.5M share IPO price $20.25 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TSLA

Tesla

$344.07

5.36 (1.58%)

19:07
11/14/18
11/14
19:07
11/14/18
19:07
Periodicals
Tesla Model 3 owners experience issues in cold weather, Electrek says »

Tesla Model 3 will face…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 19

    Nov

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.